Markets:

Overview

News

Currencies

International

Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

16.05 +0.21 (+1.29%)

Streaming Delayed Price Updated: 10:46 AM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc.

September 24, 2022

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

FULGENT GENETICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT

September 22, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

September 22, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR NOTICE: Investors in Fulgent Genetics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – FLGT

September 22, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Fulgent Genetics, Inc. Investor Alert: Robbins LLP Informs Shareholders of Class Action Against Fulgent Genetics, Inc. (FLGT)

September 21, 2022

From Robbins LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

September 21, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Fulgent Genetics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

September 21, 2022

From Rosen Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

September 21, 2022

From Law Offices of Howard G. Smith

Via Business Wire

INVESTOR ALERT: Fulgent Genetics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Fulgent Genetics Class Action Lawsuit - FLGT

September 21, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

September 21, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

September 20, 2022

From The Schall Law Firm

Via Business Wire

Fulgent Genetics's Return On Invested Capital Insights ↗

August 22, 2022

Pulled from Benzinga Pro data, Fulgent Genetics (NASDAQ:FLGT) posted Q2 earnings of $11.10 million, an increase from Q1 of 92.77%. Sales dropped to $125.34 million, a 60.86% decrease between quarters.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Fulgent Genetics, Inc. (FLGT)

August 10, 2022

From Kirby McInerney LLP

Via Business Wire

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

August 08, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 08, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

August 08, 2022

From The Schall Law Firm

Via Business Wire

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

August 07, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

August 05, 2022

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 05, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 05, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Recap: Fulgent Genetics Q2 Earnings ↗

August 04, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat...

Via Benzinga

Fulgent Genetics Reports Second Quarter 2022 Financial Results

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox

August 04, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics to Announce Second Quarter 2022 Financial Results on Thursday, August 4, 2022

July 19, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics: Q1 Earnings Insights ↗

May 03, 2022

Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Fulgent Genetics beat estimated...

Via Benzinga

Fulgent Genetics Reports First Quarter 2022 Financial Results

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Promotions and Leadership Updates

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

Fulgent Genetics Announces Opening of New State-of-the-Art Oncology Laboratory in El Monte, California

May 03, 2022

From Fulgent Genetics, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.